[1]张军茹.中西医视角治疗慢性心力衰竭合并高尿酸血症探析[J].现代中医药,2021,(03):001-5.[doi:10.13424/j.cnki.mtcm.2021.03.001]
　ZHANGJunru.TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine[J].Modern Traditional Chinese Medicine,2021,(03):001-5.[doi:10.13424/j.cnki.mtcm.2021.03.001]
点击复制

中西医视角治疗慢性心力衰竭合并高尿酸血症探析()
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年03期
页码:
001-5
栏目:
出版日期:
2021-05-20

文章信息/Info

Title:
TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine
文章编号:
1672-0571(2021)03-0001-05
作者:
张军茹1; 2
１．陕西省中医医院心内科，陕西 西安 ７１０００３；
２．陕西中医药大学，陕西 咸阳 ７１２０４６
Author(s):
ZHANGJunru1; 2
PreventiveTreatmentCenter,XiyuanHospital,ChinaAcademyofChineseMedicalSciences,Beijing100091,China
关键词:
慢性心力衰竭; 高尿酸血症; 中西医结合; 治疗
Keywords:
Chronicheartfailure; Hyperuricemia; IntegratedtraditionalChineseandWesternmedicinetreatment
分类号:
R541.6
DOI:
10.13424/j.cnki.mtcm.2021.03.001
文献标志码:
A
摘要:
慢性心力衰竭（ｃｈｒｏｎｉｃｈｅａｒｔｆａｉｌｕｒｅ，ＣＨＦ）与高尿酸血症（ｈｉｇｈｕｒｉｃａｃｉｄ，ＨＵＡ）关系紧密，互相影响。 在梳理文献的基础上，对中西医结合治疗慢性心力衰竭合并高尿酸血症的临床意义、诊治现状、存在问题进行了 系统分析，着重从中医药角度探讨了慢性心力衰竭与高尿酸血症的病理机制、治疗原则、代表复方、治疗前景。
Abstract:
Chronicheartfailure(CHF)andhyperuricemia(HUA)arecloselyrelatedandinteractwitheachother,whichhasimportantclinicalsignificance.Onthebasisofliteraturereview,thispapersystematicallyanalyzedtheclinicalsignificance,diagnosisandtreatmentstatusandexistingproblemsofintegratedtraditionalChineseandWesternmedicineinthetreatmentofchronicheartfailurewithhyperuricemia,andemphaticallydiscussedthepathologicalmechanism,treatmentprinciple,representativecompoundandtreatmentprospectofchronicheartfailureandhyperuricemiafromtheperspectiveoftraditionalChinesemedicine

参考文献/References:

[1]JHUNDPS,MacintyreK,SimpsonCR,etal.Longtermtrendsinfirsthospitalizationforheartfailureandsubsequentsurvivalbetween1986and2003:Apopulationstudyof5.1millionpeople[J].Circulation,2009,(119):515-523.
[2]BorqhiC,CosentinoER,RinaldiER,etal.Uricaemiaandejectionfractioninelderlyheartfailureoutpatients[J].EurJClinInvest,2014,44(6):573-578.
[3]PalazzuoliA,RuoccoC,PellegriniM,etal.Prognosticsignificanceofhyperuricemiainpatientswithacuteheartfailure[J].AmJCardiol,2016,117(10):1616-1621.
[4]SakaiH,TsutamotoT,TsutsuiT,etal.Serumlevelofuricacid,partlysecretedfromthefailingheart,isaprognosticmarkerinpatientswithcongestiveheartfailure[J].CircJ,2006,(70):1006-1011.
[5]叶丁容,黄娉欢,李月琼,等.血清尿酸水平与充血性心力衰竭严重程度的相关性 分 析 [J].中 外 医 疗,2020,(19):76-78.
[6]杨敏,陈广玲,吴贤仁,等.心力衰竭患者血清尿酸水平的变化[J].中国心血管病研究杂志,2006,4(4):257-259.
[7]王传合,于彤彤,董媛媛,等.高尿酸血症与慢性心力衰竭的相关性分析[J].中国动脉硬化杂志,2015,23(10):1043-1047.
[8]高芳芳,王世一,杨倩文,等.高尿酸血症对不同射血分数心力衰竭的影响[J].中国心血管杂志,2019,24(5):490-492.
[9]BoveM,CiceroAF,VeronesiM,etal.Anevidence-basedreviewonurate-loweringtreatments:implicationsforoptimaltreatmentofchronichyperuricemia[J].VascHealthRiskManag,2017,(13):23-28.
[10]何青,唐国栋.高尿酸血症与冠心病[J].中国心血管杂志,2016,21(1):1-4.
[11]HuangH,HuangB,LiY,etal.Uricacidandriskofheartfailure:asystematicreviewandmeta-analysis[J].EurJHeartFail,2014,(16):15-24
[12]ChenJH,ChuangSY,ChenHJ,etal.Serumuricacidlevelasanindependentriskfactorforallcause,cardiovascular,andischemicstrokemortality:aChinesecohortstudy[J].ArthritisRheum,2009,(61):225e32.
[13]AminA,VakilianF,MalekiM.Serumuricacidlevelscorrelatewithfillingpressuresinsystolicheartfailure:fillingpressuresinsystolicheartfailure[J].CongestHeartFail,2011,(17):79-83.
[14]单瑞,程爱娟,吴尚勤,等.苯溴马隆与别嘌醇对心力衰竭伴高尿酸血症患者炎症因子及心功能的影响[J].中华高血压杂志,2014,4(22):380382.
[15]张倩,杨星林.非布司他对伴高尿酸血症的老年慢性心力衰竭患者心功能的影响[J].中国心血管杂志,2018,23(6):468-469.
[16]HareJM,MangalB,BrownJ,eta1.Impactofoxypurinolinpatientswithsymptomaticheartfailure.ResultsoftheOPTCHFstudy[J].JAmCollCardiol,2008,(51):2301-2309.
[17]GivertzMM,AnstromKJ,RedfifieldMM,eta1.Effectsofxanthineoxidaseinhibitioninhyperuricemicheartfailurepatients:theXanthineOxidaseInhibitionforHyperuricemicHeartFailurePatients(EXACT-HF)study[J].Circulation,2015,(131):1763-71.
[18]WhiteWB,SaagKG,BeckerMA,eta1.Cardiovascularsafetyoffebuxostatorallopurinolinpatientswithgout[J].NEngJMed,2018,378(13):1200-1210.
[19]孔晓艳,鲁一兵.GLT2抑制剂对 2型糖尿病患者血尿酸水平的影响[J].国际内分泌代谢杂志,2020,(2):97-99.
[20]InzucchiSE,ZinmanB,FitchettD,etal.Howdoesempagliflflozinreducecardiovascularmortality?InsightsfromamediationanalysisoftheEMPA-REGOUTCOMEtrial[J].DiabetesCare,2018,(41):35663.
[21]LiJW,WoodwardM,PerkovicV,etal.Mediatorsoftheeffectsofcanagli-flflozinonheartfailureinpatientswithtype2diabetes[J].JACCHeartFail,2020,(8):57-66.
[22]VERMAS,JIQH,BHATTDL,etal.Associationbetweenuricacidlevelsandcardio-renaloutcomesanddeathinpatientswithtype2diabetes:asubanalysisofEMPA-REGOUTCOME[J].DiabetesObesMetab,2020,22(7):1207-1214.
[23]KosiborodMN,JhundPS,DochertyKF,etal.Effectsofdapagliflozinonsymptoms,function,andqualityoflifeinpatientswithheartfailureandreducedejectionfraction:ResultsfromtheDAPA-HFtrail[J].Circulation,2020,141(2):90-99.
[24]MartinezFA,SerenelliM,NicolauJC,etal.Efficacyandsafetyofdapagliflozininheartfailurewithreducedejectionfractionaccordingtoage:insightsFrom DAPA-HF[J].Circulation,2020,141(2):100111.
[25]刘风琴.化湿降浊方干预慢性心力衰竭伴高尿酸血症患者临床研究[D].黄芪南京中医药大学,2016.
[26]唐群.益气活血利水法治疗气虚血瘀型慢性心力衰竭合并高尿酸血症的疗效[J].医学信息,2020,33(12):152-154.
[27]孙晓妮.中医方药配合抗心衰药物治疗慢性心力衰竭伴高尿酸血症的疗效分析[J].内蒙古中医药,2020,39,(5):25-26.
[28]严容,彭吉新,徐佳杨,等.中西医结合治疗慢性心力衰竭合并高尿酸血症 40例总结[J].湖南中医杂志,2020,36(10):25-28.
[29]张阳阳,郑刚,任耀龙,等.慢性心力衰竭合并高尿酸血症患者的中医证素分布规律研究[J].中国中医急症,2020,29(6):974-976.
[30]张军茹.从心肾同病?阴阳互根角度看慢性充血性心力衰竭的防治[J].医学信息,2011,24(12):730-731.
[31]张军茹,张冠杰.“阳化气?阴成形”理论及其在心衰治疗中应用价值探讨[J].中医药临床杂志,2014,26(4):336-337.
[32]张军茹,任得志.养心合剂治疗慢性心力衰竭临床观察[J].陕西中医,2015,36(2):143-144.
[33]张军茹.基于津气并调论慢性心衰的容量管理[J].陕西中医药大学学报,2020,43(1):34-36,53.
[34]刘风琴,顾宁.慢性心力衰竭合并高尿酸血症的中西医研究进展[J].现代中西医结合杂志,2016,25(13):1480-1482.
[35]孙晓妮.中医方药配合抗心衰药物治疗慢性心力衰竭伴高尿酸血症的疗效分析[J].内蒙古中医药,2020,39(05):25-26.
[36]杨明月.益心定悸方Ⅱ号治疗慢性心力衰竭(气虚血瘀型)伴高尿酸血症临床疗效观察[D].哈尔滨:黑龙江中医药大学,2019.
[37]李立荣.四妙丸加减配合耳穴压豆治疗慢性心力衰竭合并高尿酸血症的临床观察[J].中医临床研究,2019,11(20):34-36.

相似文献/References:

[1]唐婉莹.益气活血利水法治疗慢性心力衰竭的疗效观察[J].现代中医药,2019,(05):058.[doi:10.13424/j.cnki.mtcm.2019.05.018]
[2]夏柔娟 蒙广阔 *.心衰合剂治疗慢性心力衰竭临床疗效观察[J].现代中医药,2018,(06):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
　Xia Roujuan Meng Guangkuo.Clinical Observation of Heart Failure Mixture in Treating Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2018,(03):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
[3]杨嘉豪 徐建虎.温阳消饮法对慢性心力衰竭模型 大鼠血清 ＡＮＰ、ＴＮＦ－α及 ＩＬ－６水平影响[J].现代中医药,2019,(02):092.[doi:10.13424/j.cnki.mtcm.2019.02.028]
　Yang Jiahao Xu Jianhu.Effect of the Therapy of Warming Yang to Resolve Fluid Retention on Serum ANP, TNF -α and IL -6 Levels in Rats with Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2019,(03):092.[doi:10.13424/j.cnki.mtcm.2019.02.028]
[4]田 心.从中医“圆运动”谈慢性心力衰竭诊疗指南的药物应用[J].现代中医药,2021,(02):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
　TIAN Xin.Discussion on Drug Application of Chronic Heart Failure Diagnosis and Treatment Guidelines from circular movement of Chinese Medicine[J].Modern Traditional Chinese Medicine,2021,(03):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
[5]杜永波** 杨建伟 王梅梅 徐新松王洪杰.基于心功能及氧化应激指标探析附萸汤 治疗慢性心力衰竭的有效性[J].现代中医药,2023,(05):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
　DU Yongbo YANG Jianwei WANG Meimei XU Xinsong WANG Hongjie.Effectiveness of Fuyu Decoction in Treating Chronic Heart Failure Based on Cardiac Function and Oxidative Stress Indicators[J].Modern Traditional Chinese Medicine,2023,(03):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
[6]王铭马立旭 王秀萍韩金荣 徐建虎.消饮化瘀方对慢性心力衰竭大鼠NTproBNP及GPR35mRNA水平的影响[J].现代中医药,2023,(05):113.[doi:10.13424/j.cnki.mtcm.2023.05.021]

备注/Memo

备注/Memo:
基金项目：第四批全国优秀临床人才项目（国中药人教发［２０１７］２４号）
更新日期/Last Update: 2021-06-08